Atlas Trials

Silence Therapeutics plc

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Silence Therapeutics plc

RecordFirmDate
Study to Assess SLN124 in Patients With Polycythemia Vera (NCT05499013)Silence Therapeutics plc2023-01-26
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events (NCT05537571)Silence Therapeutics plc2022-12-13
A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome (NCT04718844)Silence Therapeutics plc2021-04-14
Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) (NCT04606602)Silence Therapeutics plc2020-11-18
A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers (NCT04559971)Silence Therapeutics plc2020-09-03
Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124 (NCT04176653)Silence Therapeutics plc2019-08-20

Track Silence Therapeutics plc automatically

Every clearance here is in the API, with alerts when new ones post.